Xxera/openscience/retractions

Record #52780

Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder

Mahmoud S Abdallah, Ahmed N Ramadan, Hend Omara-Reda, Noha O Mansour, Mohamed A Elsokary, Hozaifa K Elsawah, Shimaa Abdelsattar Zaki, Hend E Abo Mansour, Esraa M Mosalam

Journal

CNS Neuroscience & Therapeutics

Publisher

Original paper date

Sep 21, 2021

Original DOI

10.1111/cns.13731

Country

Institution

Department of Clinical Pharmacy, Faculty of Pharmacy, University of Sadat City, Sadat City, Egypt · Department of Neuropsychiatry, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt · Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt · Department of Biostatistics, High Institute of Public Health, Alexandria University, Alexandria, Egypt · Department of Clinical Biochemistry and Molecular Diagnostics, National Liver Institute, Menoufia University, Shebin El-Kom, Egypt · Department of Biochemistry, Faculty of Pharmacy, Menoufia University, Shebin El-Kom, Egypt

Open access

No

Article type

Broad categories

(HSC) Medicine - Neurology (HSC) Medicine - Pharmacology (HSC) Medicine - Psychiatry (HSC) Medicine - Rehabilitation/Therapy

Citation lifecycle

How this paper is being cited

Pre-retraction

13

Same day

0

Post-retraction

3

% post-retraction

18.8%

~5.3 citations/yr before retraction · ~1.2 citations/yr after

— citing papers

Who is still citing this work

Loading…